Enliven Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:ELVN) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 12.19 M17.2 M24.13 M17.06 M13.28 M 71.67 M Cash from investing activities -14.83 M-727 K1.43 M180.74 M4.06 M 185.49 M Cash from financing activities 1.12 M39.97 M234 K218.38 M-368 K 258.22 M Free cash flow 12.17 M17.2 M24.11 M16.92 M13.28 M 71.51 M

ニュース

Enliven Therapeutics取締役のHeyman氏、3万2000ドル相当の株式を売却

Heyman, Enliven Therapeutics director, sells $32k in stock

リシカトス氏、エンライブン・セラピューティクスのCSO、14.5万ドル相当の株式を売却

Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares

Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock

エンライブン・セラピューティクス取締役ヘイマン氏、32,901ドル相当の株式を売却

Enliven Therapeutics director Heyman sells $32,901 in stock

Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN

Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious

エンライブン・セラピューティクスのCSO、リシカトスが347万ドル相当の株式を売却

Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares

Enliven Therapeuticsの株価、52週高値の25.64ドルに到達